Vivani Medical, Inc.
VANI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $105 | $0 | $0 | $89 |
| Gross Profit | -$105 | $0 | $0 | -$89 |
| % Margin | – | – | – | – |
| R&D Expenses | $4,519 | $4,759 | $4,217 | $4,297 |
| G&A Expenses | $0 | $2,703 | $2,340 | $0 |
| SG&A Expenses | $2,101 | $2,703 | $2,340 | $2,074 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6,620 | $7,462 | $6,557 | $6,371 |
| Operating Income | -$6,725 | -$7,462 | -$6,557 | -$6,460 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $195 | $318 | $255 | $410 |
| Pre-Tax Income | -$6,530 | -$7,144 | -$6,302 | -$6,050 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6,530 | -$7,144 | -$6,302 | -$6,050 |
| % Margin | – | – | – | – |
| EPS | -0.11 | -0.12 | -0.11 | -0.11 |
| % Growth | 8.3% | -9.1% | 0% | – |
| EPS Diluted | -0.11 | -0.12 | -0.11 | -0.11 |
| Weighted Avg Shares Out | 59,711 | 59,244 | 59,236 | 57,423 |
| Weighted Avg Shares Out Dil | 59,711 | 59,244 | 59,236 | 57,423 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $18 | $102 | $102 | $89 |
| EBITDA | -$6,512 | -$7,360 | -$6,455 | -$5,961 |
| % Margin | – | – | – | – |